PODCAST
New Hot Flash Drug, Brain Fog Solutions, and Military Menopause Gaps
May 4, 2026·7:13·Episode 28
Quick Summary
New research highlights promising developments in menopause treatment and identifies important gaps. A novel hot flash medication shows good results in Chinese women, researchers are developing targeted interventions for brain fog, and the first systematic review of military menopause reveals significant knowledge gaps that could affect women in high-stress careers.
New Hot Flash Drug, Brain Fog Solutions, and Military Menopause Gaps
0:000:00
Key Takeaways
- ✦GS1-144, a new neurokinin 3 receptor antagonist, significantly reduced hot flash frequency and severity in Chinese women with good safety profile
- ✦Researchers are developing evidence-based psychosocial interventions specifically for cognitive symptoms during menopause transition, treating brain fog as a legitimate medical concern
- ✦The first systematic review of military menopause research revealed major knowledge gaps about how symptoms interact with combat roles, deployment, and extreme environments
- ✦Menopause research is becoming more targeted, addressing specific populations and circumstances rather than assuming one-size-fits-all approaches
- ✦Military menopause research could eventually benefit civilian women in other high-stress, high-performance careers
Sources & References
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.